CJC-1295 with DAC – Extended-Release GHRH Research Peptide

CJC-1295 with DAC is a modified growth hormone-releasing hormone analog designed for extended biological activity. The Drug Affinity Complex (DAC) component makes it particularly relevant for research involving sustained peptide activity and growth hormone signaling pathways.

Key Research Areas

1. Extended Biological Activity

   Designed for research involving prolonged peptide circulation.

2. Growth Hormone Signaling

   Studied for its interaction with GHRH-related pathways.

3. IGF-1 Research

   Investigated in studies examining downstream growth-factor signaling.

4. Pulsatile Hormonal Research

   Relevant to research involving natural hormone-release mechanisms.

5. Advanced Endocrine Studies

   A valuable compound for extended-duration peptide and hormonal research.